{"name":"Sartorius","slug":"sartorius","ticker":"SRT3.DE","exchange":"XETRA","domain":"sartorius.com","description":"Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufactu","hq":"Goettingen, Germany","founded":1927,"employees":"14242","ceo":"Joachim Kreuzburg","sector":"Bioprocess Equipment / Lab Instruments","stockPrice":213.5,"stockChange":2.1,"stockChangePercent":0.99,"marketCap":"$17.2B","metrics":{"revenue":4151617733.5176187,"revenueGrowth":1.8,"grossMargin":45.6,"rdSpend":0,"netIncome":189931076.27999997,"cash":670248779.64,"dividendYield":0.35,"peRatio":90.9,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-09-14","type":"earnings","headline":"Sartorius Reports Strong Q3 2023 Results","summary":"Sartorius reported strong Q3 2023 results, with revenue growth of 15.6% and adjusted EBITDA margin of 24.1%. The company's bioprocess segment drove growth, with revenue increasing by 18.3%.","drugName":"","sentiment":"positive"},{"date":"2023-06-15","type":"deal","headline":"Sartorius Acquires Cell Culture Media Business from Corning","summary":"Sartorius acquired the cell culture media business from Corning, expanding its portfolio of bioprocess solutions.","drugName":"","sentiment":"positive"},{"date":"2022-11-10","type":"regulatory","headline":"Sartorius Receives FDA Clearance for BioPAT","summary":"Sartorius received FDA clearance for its BioPAT product, a bioprocess monitoring system.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQTG91ZGY5ZmxycllwWDA0S2RHWlplaEZzQUJLenJVOWxKaXpSLWRPV0tfRXFla18wamNMaFVKcVdhZWZCX2xyUElwRWhDSDZFNG95U19wOHhNLU4xRS13elpRTHhMT2l5TFdfY0FqNGxKcU1YdjlBOUZfSDdaMkNoVWNrUXpkaGJ0TkpYaWlNRXYyak11d1FSNU16N1MzdGRJMjNnSEIxNGhkRkZTOS1jWHEtc2d4RkhuNUpod0p3MzJFd1ZHR0hTNzBjaDhVa3kzWUhIZlNnR3cxc3YyWUd4VtIB5gFBVV95cUxQTG5vSEdQMW0wZENmQXRfUVlZVUtnRnRFRFdubUZoUFdIVzgtSlB1dWYteDVMMlNqdzNCYnR6dkdxNmZENHAyS1R6aGJvc1F0TjNScjVfd0ZOd2VZTk1FWk1pRDBVWnYxQUUxVFVlaFU1bkZLOWRMajZ0LVdhSzR4YUZvcUoya1VsOTV0WFpISG9ZWWswTlhmVnV4bmdsQVlCMUEtMG80Y3Y1eVd0Qk5TOFBxekdTQlY5SXltODItRmlTQ0hYVkpkeGxwc0toWU8wYnYtZ3hLUWFrZWl6eEwxRl9NdmplQQ?oc=5","date":"2026-02-08","type":"earnings","source":"simplywall.st","summary":"Sartorius Q4 Margin Miss Shifts Focus To Earnings Quality And Mix - simplywall.st","headline":"Sartorius Q4 Margin Miss Shifts Focus To Earnings Quality And Mix","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxORVczUEktaG9PZ1dkMjMxWTk1TDZlUVFCX0dvbFZ6eEJTd2VXVmlFZWZZNXI0WUJ0UUFtMm4xanpSOTc0YS1VRHhBLUJ5dlBTRUxQMTNiTEkwQ2gwS1NnU3VwX1EyUVFEdVFTMmxBd0I0bDdkYTFLMTUxQzdxSFJOeG9VbXhMQTJqdmZrZ3dDN3ROMTJTaWc?oc=5","date":"2024-11-11","type":"pipeline","source":"Morningstar","summary":"Bio-Rad Laboratories: This Undervalued Stock Offers Investors a Rare Combination - Morningstar","headline":"Bio-Rad Laboratories: This Undervalued Stock Offers Investors a Rare Combination","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOVjd1TWZ1cWtxQkxwNWx6d2ROcUVnLUVSbVpBa3VWM25jMHpneERVSWdNU01VTm5tRElLZWdMbnl4UHVHSkhweVR3M0NXRGJ0UWFEaFNsWjZ2SGlOMjN6U1dvQUZWUVJrd3FSRXhYZ1V6d0diNjM5VjBqMktRVmlzbHBLRS1nYVY5V09XVWE1MUhNY2gxMi1JZkln?oc=5","date":"2023-02-03","type":"pipeline","source":"Seeking Alpha","summary":"Sartorius Stock: Combating And Benefiting From Eroom's Law (OTCMKTS:SARTF) - Seeking Alpha","headline":"Sartorius Stock: Combating And Benefiting From Eroom's Law (OTCMKTS:SARTF)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE8zNWtZUzZfVGF0b0Q0QjRTdFUtblo5YmthOWhxSGhaYkxHT3VpbnNRQks5Qm04amVhS01tV1AxajFzY0g4Rm1rbHdxYkduNWg3TmNSdU5FRGc?oc=5","date":"2017-08-16","type":"pipeline","source":"TradingView","summary":"SRT Stock Price and Chart — XETR:SRT - TradingView","headline":"SRT Stock Price and Chart — XETR:SRT","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Thermo Fisher Scientific","Danaher Corporation","Agilent Technologies"],"therapeuticFocus":["Bioprocess Technology","Laboratory Instruments"],"financials":{"source":"yahoo_finance","revenue":4132811445.18,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":4132811445.18},{"period":"2024-12-31","value":3948954425.4599996},{"period":"2023-12-31","value":3966475742.4599996},{"period":"2022-12-31","value":4876416138.66}],"grossProfit":1911809302.2599998,"grossProfitHistory":[{"period":"2025-12-31","value":1911809302.2599998},{"period":"2024-12-31","value":1780633042.32},{"period":"2023-12-31","value":1831094435.2799997},{"period":"2022-12-31","value":2544212037.18}],"rdSpend":203247277.2,"rdSpendHistory":[{"period":"2025-12-31","value":203247277.2},{"period":"2024-12-31","value":229879679.04},{"period":"2023-12-31","value":199509396.23999998},{"period":"2022-12-31","value":209321333.76}],"sgaSpend":1047307521.4799999,"operatingIncome":664875575.76,"operatingIncomeHistory":[{"period":"2025-12-31","value":664875575.76},{"period":"2024-12-31","value":510687986.15999997},{"period":"2023-12-31","value":635322954.42},{"period":"2022-12-31","value":1330802430.54}],"netIncome":180936800.22,"netIncomeHistory":[{"period":"2025-12-31","value":180936800.22},{"period":"2024-12-31","value":98119375.19999999},{"period":"2023-12-31","value":240158851.67999998},{"period":"2022-12-31","value":792080337.18}],"eps":2.24,"epsHistory":[{"period":"2025-12-31","value":2.24},{"period":"2024-12-31","value":1.21},{"period":"2023-12-31","value":3},{"period":"2022-12-31","value":9.91}],"cash":632402734.92,"cashHistory":[{"period":"2025-12-31","value":632402734.92},{"period":"2024-12-31","value":950122616.5199999},{"period":"2023-12-31","value":442938893.76},{"period":"2022-12-31","value":193785766.01999998}],"totalAssets":11350542770.16,"totalLiabilities":6833196821.219999,"totalDebt":5002336003.5,"equity":3161780057.04,"operatingCashflow":977689488.5999999,"operatingCashflowHistory":[{"period":"2025-12-31","value":977689488.5999999},{"period":"2024-12-31","value":1140287310.36},{"period":"2023-12-31","value":997079746.0799999},{"period":"2022-12-31","value":857610062.7599999}],"capex":-516177998.81999993,"capexHistory":[{"period":"2025-12-31","value":-516177998.81999993},{"period":"2024-12-31","value":-478799189.21999997},{"period":"2023-12-31","value":-653778741.66},{"period":"2022-12-31","value":-610442684.28}],"freeCashflow":461511489.78,"dividendsPaid":-59338860.239999995,"buybacks":null,"employees":14242,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":258497830.14,"ebit":203247277.2,"ebitda":327765436.67999995,"period":"2026-03-31","revenue":1050227740.9799999,"epsBasic":0.81,"netIncome":65646534.35999999,"rdExpense":57353110.98,"epsDiluted":0.81,"grossProfit":484172393.09999996,"operatingIncome":179651903.64},{"sga":257913786.23999998,"ebit":77794647.47999999,"ebitda":206868349.38,"period":"2025-12-31","revenue":1083518243.28,"epsBasic":null,"netIncome":108865782.96,"rdExpense":49293305.16,"epsDiluted":null,"grossProfit":462796386.35999995,"operatingIncome":198808543.55999997},{"sga":263053372.55999997,"ebit":154187589.6,"ebitda":273916589.09999996,"period":"2025-06-30","revenue":1032940041.54,"epsBasic":0.47,"netIncome":37962853.5,"rdExpense":48592452.48,"epsDiluted":0.47,"grossProfit":486158142.35999995,"operatingIncome":154070780.82},{"sga":270879560.82,"ebit":224623283.93999997,"ebitda":345520371.23999995,"period":"2025-03-31","revenue":1031421527.3999999,"epsBasic":0.7,"netIncome":56652258.3,"rdExpense":58053963.66,"epsDiluted":0.7,"grossProfit":503445841.79999995,"operatingIncome":160612072.5},{"sga":254993566.73999998,"ebit":34458590.099999994,"ebitda":173461038.29999998,"period":"2024-12-31","revenue":1059222017.04,"epsBasic":null,"netIncome":51863098.31999999,"rdExpense":69384415.32,"epsDiluted":null,"grossProfit":460927445.87999994,"operatingIncome":163532292},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":0.21,"netIncome":null,"rdExpense":null,"epsDiluted":0.21,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":213.5,"previousClose":211.4,"fiftyTwoWeekHigh":267.7,"fiftyTwoWeekLow":175.95,"fiftyTwoWeekRange":"175.95 - 267.7","fiftyDayAverage":217.83,"twoHundredDayAverage":225.47,"beta":1.4,"enterpriseValue":22764692612.070602,"forwardPE":33.4,"priceToBook":5.45,"priceToSales":4.15,"enterpriseToRevenue":5.48,"enterpriseToEbitda":21.52,"pegRatio":0.94,"ebitda":1057703540.2788095,"ebitdaMargin":25.5,"freeCashflow":365845098.96,"operatingCashflow":1035743489.6388096,"totalDebt":5023828632.125952,"debtToEquity":110.5,"currentRatio":0.91,"returnOnAssets":3.7,"returnOnEquity":6.2,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":19,"targetMeanPrice":264.42,"targetHighPrice":307,"targetLowPrice":190,"dividendRate":0.74,"payoutRatio":0.31,"fiveYearAvgDividendYield":0.32,"exDividendDate":1774569600,"insiderHeldPercent":25.6,"institutionHeldPercent":31.4,"sharesOutstanding":34813621,"floatShares":27453809,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":2.35,"epsForward":6.4,"revenuePerShare":51.24,"bookValue":39.2,"officers":[{"age":58,"name":"Dr. Michael  Grosse","title":"CEO & Chairman of the Executive Board"},{"age":54,"name":"Dr. Florian  Funck Dipl.Kfm.","title":"CFO & Member of Executive Board"},{"age":50,"name":"Dr. Rene  Faber","title":"Head of Bioprocess Solutions Division & Member of Executive Board"},{"age":46,"name":"Dr. Alexandra  Gatzemeyer","title":"Head of the Lab Products & Services Division and Member of Executive Board"},{"age":null,"name":"Ms. Patricia  Spannagel","title":"Head of Quality Assurance - Mechatronics Division Goettingen"},{"age":null,"name":"Ralf  Mohrschladt","title":"Physicist & Head of Supply Chain Management - Germany"},{"age":null,"name":"Ms. Petra  Muller","title":"Head of Investor Relations"},{"age":null,"name":"Mr. Maurice  Phelan","title":"President of Sartorius North America"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.sartorius.com","phone":"49 551 308 0"}}